Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term colony-stimulating factor. Found 23 abstracts

no pagination
Hurria A, Browner IS, Cohen HJ, Denlinger CS, deShazo M, Extermann M, Ganti AK, Holland JC, Holmes HM, Karlekar MB, Keating NL, McKoy J, Medeiros BC, Mrozek E, O'Connor T, Petersdorf SH, Rugo HS, Silliman RA, Tew WP, Walter LC, Weir AB, Wildes T. Senior Adult Oncology. Journal of the National Comprehensive Cancer Network. 2012 Feb;10(2):162-209.   PMCID: not NIH funded
Crawford J, Allen J, Armitage J, Blayney DW, Cataland SR, Heaney ML, Htoy S, Hudock S, Kloth DD, Kuter DJ, Lyman GH, McMahon B, Steensma DP, Vadhan-Raj S, Westervelt P, Westmoreland M. Myeloid Growth Factors. Journal of the National Comprehensive Cancer Network. 2011 Aug;9(8):914-+.   PMCID: not NIH funded
Kalemkerian GP, Akerley W, Bogner P, Borghaei H, Chow L, Downey RJ, Gandhi L, Ganti AK, Govindan R, Grecula JC, Hayman J, Heist RS, Horn L, Jahan TM, Koczywas M, Moran CA, Niell HB, O'Malley J, Patel JD, Ready N, Rudin CM, Williams CC. Small Cell Lung Cancer. Journal of the National Comprehensive Cancer Network. 2011 Oct;9(10):1086-113.   PMCID: not NIH funded
Slingluff CL, Petroni GR, Chianese-Bullock KA, Smolkin ME, Ross MI, Haas NB, Von Mehren M, Grosh WW. Randomized Multicenter Trial of the Effects of Melanoma-Associated Helper Peptides and Cyclophosphamide on the Immunogenicity of a Multipeptide Melanoma Vaccine. Journal of Clinical Oncology. 2011 Jul;29(21):2924-32.   PMCID: PMCID: PMC3138719[Available on 2012/7/20]
Gupta V, Tallman MS, He WS, Logan BR, Copelan E, Gale RP, Khoury HJ, Klumpp T, Koreth J, Lazarus HM, Marks DI, Martino R, Rizzieri DA, Rowe JM, Sabloff M, Waller EK, DiPersio JF, Bunjes DW, Weisdorf DJ. Comparable survival after HLA-well-matched unrelated or matched sibling donor transplantation for acute myeloid leukemia in first remission with unfavorable cytogenetics at diagnosis. Blood. 2010 Sep;116(11):1839-48.   PMCID: PMC3173984
Yurkovetsky Z, Skates S, Lomakin A, Nolen B, Pulsipher T, Modugno F, Marks J, Godwin A, Gorelik E, Jacobs I, Menon U, Lu K, Badgwell D, Bast RC, Lokshin AE. Development of a Multimarker Assay for Early Detection of Ovarian Cancer. Journal of Clinical Oncology. 2010 May;28(13):2159-66.   PMCID: PMCID 2860434 [Available on 2011/5/1]
Roberts JD, Smith MR, Feldman EJ, Cragg L, Millenson MM, Roboz GJ, Honeycutt C, Thune R, Padavic-Shaller K, Carter WH, Ramakrishnan V, Murgo AJ, Grant S. Phase I study of bryostatin 1 and fludarabine in patients with chronic lymphocytic leukemia and indolent (Non-Hodgkin's) lymphoma. CLINICAL CANCER RESEARCH. 2006 Oct;12(19):5809-16.
Seebach JD, Stussi G, Passweg JR, Loberiza FR, Gajewski JL, Keating A, Goerner M, Rowlings PA, Tiberghien P, Elfenbein GJ, Gale RP, van Rood JJ, Reddy V, Gluckman E, Bolwell BJ, Klumpp TR, Horowitz MM, Ringden O, Barrett AJ. ABO blood group barrier in allogeneic bone marrow transplantation revisited. Biology of Blood and Marrow Transplantation. 2005 Dec;11(12):1006-13.
von Mehren M. Colorectal cancer vaccines: What we know and what we don't yet know. Seminars in Oncology. 2005 Feb;32(1):76-84.
Cohen SJ, Meropol NJ. Drug development in pancreatic cancer - Finally, biology begets therapy. International Journal of Gastrointestinal Cancer. 2002 Jan;32(2-3):91-106.
Schilder RJ, Johnson S, Gallo J, Kindsfather S, Rogers B, Bookman MA, Millenson MM, Boente M, Rosenblum N, Litwin S, Ozols RF. Phase I trial of multiple cycles of high-dose chemotherapy supported by autologous peripheral-blood stem cells. Journal of Clinical Oncology. 1999 Jul;17(7):2198-207.
Alpaugh RK, von Mehren M, Palazzo I, Atkins MB, Sparano JA, Schuchter L, Weiner LM, Dutcher JP. Phase IB trial for malignant melanoma using R24 monoclonal antibody, interleukin-2/alpha-interferon. Medical Oncology. 1998 Sep;15(3):191-8.
Bookman MA. Biological therapy of ovarian cancer: Current directions. Seminars in Oncology. 1998 Jun;25(3):381-96.
Schilder RJ, Shea TC. Multiple cycles of high-dose chemotherapy for ovarian cancer. Seminars in Oncology. 1998 Jun;25(3):349-55.
Ford PA, Arbuck SG, Minniti C, Miller LL, DeMaria D, Odwyer PJ. Phase I trial of etoposide, doxorubicin and cisplatin (EAP) in combination with GM-CSF. European Journal of Cancer. 1996 Apr;32A(4):631-5.
Clark JI, Weiner LM. Biologic Treatment of Human Cancer. Current Problems in Cancer. 1995 Jul;19(4):190-262.
Kotz KW, Schilder RJ. High-Dose Chemotherapy and Hematopoietic Progenitor-Cell Support for Patients with Epithelial Ovarian-Cancer. Seminars in Oncology. 1995 Jun;22(3):250-62.
Scher RM, Kosierowski R, Lusch C, Alexander R, Fox S, Redei I, Green F, Raskay B, Amfoh K, Engstrom PF, Odwyer PJ. Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas. Investigational New Drugs. 1995 Jan;13(4):347-54.
Sledge GW, Robert N, Sparano JA, Cogleigh M, Goldstein LJ, Neuberg D, Rowinsky E, Baughman C, McCaskillstevens W. Eastern-Cooperative-Oncology-Group Studies of Paclitaxel and Doxorubicin in Advanced Breast-Cancer. Seminars in Oncology. 1995 Jun;22(3):105-8.
Roth BJ, Dreicer R, Einhorn LH, Neuberg D, Johnson DH, Smith JL, Hudes GR, Schultz SM, Loehrer PJ. Significant Activity of Paclitaxel in Advanced Transitional- Cell Carcinoma of the Urothelium - a Phase-Ii Trial of the Eastern-Cooperative-Oncology-Group. Journal of Clinical Oncology. 1994 Nov;12(11):2264-70.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term colony-stimulating factor

colony-stimulating factor chemotherapy phase-i trial NCCN Clinical Practice Guidelines NCCN Guidelines trial bone-marrow transplantation breast-cancer etoposide cisplatin lung-cancer randomized trial non-hodgkins-lymphoma expression phase-i metastatic melanoma doxorubicin cyclophosphamide pancreatic cancer gynecologic-oncology-group carboplatin intensive therapy stem-cell transplantation elderly-patients Her-2 1993 lisle l-archives of internal medicine-v153-p746 fever metastatic colorectal-cancer 1992 ristman k-jama-journal of the american medical association-v268-p57 recombinant fowlpox virus R24 infusion intercellular-adhesion molecule-1 bispecific monoclonal- cytotoxicity gd3 hematopoietic rescue chemotherapy-induced 2002 rischilles e-v9-p203 older patient human chorionic-gonadotropin cells alpha-IFN recombinant interferon-gamma senior adult donor bone marrow transplantation surgical chronic myelogenous leukemia adults induction incompatibility combination low-grade lymphoma phase-ii daily thoracic radiotherapy 1993 eilly se-journal of clinical oncology-v11-p2250 risk stage-iii protein-kinase-c ABO blood groups nitrate 1987 arlson me-journal of chronic diseases-v40-p373 2008 mmcdevitt j-oncology-v22-p1060 tumor-necrosis-factor randomized-trial granulocyte cytotoxic t-lymphocytes mediated-immunity radiation sensitizer identical siblings prednisone plus thalidomide cisplatin plus neuroendocrine tumors VEGF forthcoming 7th edition elderly GVHD non- small taxol immunodeficiency-virus type-1 phase-iii trial phase I trial antitumor immune-response ovarian-cancer topotecan multicenter randomized-trial agent bryostatin-1 activated killer-cells matrix metalloproteinase inhibitors Oncology serum tumor-markers monoclonal-antibody vaccine GM-CSF interleukin-2 gastric-cancer dendritic cells inappropriate medication use poor-prognosis class-i prognostic-factor human carcinoembryonic antigen advanced colorectal-carcinoma cancer-patients induced febrile morbidity advanced age ganglioside cancer treatment aplasia monoclonal-antibody topoisomerase-i inhibitors positron-emission-tomography engraftment phorbol ester mini-nutritional assessment 1995 evallier b-v13-p1564 camptothecin activated inhibitor support cell quality-of-life mortality recombinant gamma-interferon urinary-tract 2008 mmcdevitt j-oncology-v22-p1058 cyst fluids dna topoisomerase-i controlled phase-iii cell lung-cancer metaanalysis hematopoietic progenitor cells comprehensive geriatric assessment versus-host-disease FTI hodgkins-lymphoma clonogenic response assessment cell-lung-cancer antibodies neu solid interferon t-lymphocytes blood progenitor cells cpt-11 growth-factor receptor survival
Last updated on Friday, January 03, 2020